Description
Composition- Teneligliptin + Dapagliflozin + Metformin
Mode of Action- Combines incretin enhancement, renal glucose excretion and insulin sensitization for comprehensive glycemic control.
USPs- Triple mechanism diabetes therapy; controls fasting and postprandial glucose; useful in uncontrolled type 2 diabetes.
Prescribing Specialties- Diabetologist, Internal Medicine
